Polyrizon anticipates completing the brand development process in alignment with its ongoing clinical and regulatory milestones.
NEW YORK, NY / ACCESS Newswire / April 2, 2025 / If you suffered a loss on your ICON Public Limited Company (NASDAQ:ICLR) investment and want to ...